E-Swin

E-Swin specialises in corneal topography systems and analysers, which are primarily used for assessing the ocular surface. These devices help evaluate parameters like corneal curvature and tear film metrics, such as those measured by the TearCheck T for dry eye analysis and the E>EyeC for corneal mapping. The focus is on tools that support clinical diagnostics in ophthalmology.

E-Swin is based in the United States. Since its devices are authorised under FDA pathways, the company’s location aligns with U.S. regulatory requirements. The FDA’s 510(k) and UDI registries list its products, confirming compliance with U.S. medical device regulations, though individual devices—not the company—are authorised.

E-Swin’s devices appear in the FDA’s 510(k) and UDI registries. The 510(k) pathway demonstrates that these products meet FDA standards for safety and effectiveness through a premarket submission process, while UDI registration ensures unique identification for tracking and compliance. Both listings reflect the company’s adherence to U.S. regulatory frameworks for its Class I and Class II devices.

E-Swin’s devices are classified as either Class I or Class II under FDA regulations. Class I devices generally pose minimal risk and may require general controls, while Class II devices involve moderate risk and require special controls to ensure safety and performance. The classification depends on factors like the device’s intended use and potential health impact, as outlined in FDA guidelines.